Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia: a Randomized Clinical Trial

NCT06062953 is registered in ClinicalTrials.gov with Lone Baandrup as lead sponsor.

NCT NCT06062953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06062953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia: a Randomized Clinical Trial
Lead sponsor
Lone Baandrup
Phase
Phase 2/3
Overall status
Recruiting
Start date
September 18, 2023
Completion date
February 28, 2029
Enrollment
255 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, psychiatric disorders